Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where pharma pros shared practical solutions to age-old trial challenges. Kim provides a pragmatic viewpoint on the problematic trio of clinical trials—study execution, recruitment, and engagement—and what change agents are needed to pave the way forward and find an exit from the bottlenecks. Plus, host Deborah Borfitz delivers the latest on a planned mapping of clinical trial deserts, the high cost of accelerated FDA approvals, the best states for cancer research, the world’s first in-ear EEG system getting approved, and a new smartphone-based outcome measure for sleep studies. 

 News Roundup 

Financial hurdles to trial enrollment 

• Study in the Journal of the National Comprehensive Cancer Network 
• News on the Case Western Reserve University website  

Accelerated cancer drug approvals 

• Study in BMJ Medicine 

Best states for cancer research 

• Blog on SmileHub website 

In-ear EEG devices 

• Article in Diagnostics World News 

Ecological momentary assessment in sleep-focused trial 

• Study in JAMA Network Open 

Guest 

Joseph Kim, chief strategy officer for ProofPilot 

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.